Literature DB >> 15103671

Efficacy of Enicostemma littorale in Type 2 diabetic patients.

Umesh M Upadhyay1, Ramesh K Goyal.   

Abstract

Pills prepared from Enicostemma littorale (Gentianaceae) were administered to 84 patients with Type 2 Diabetes for three months. Estimation of various biochemical parameters showed that E. littorale reduced blood glucose as well as serum insulin levels and prevented the progression of complications in diabetic patients. Significant improvement in kidney function, lipid profile and blood pressure was observed suggesting that E. littorale is an effective herbal antidiabetic. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15103671     DOI： 10.1002/ptr.1434

Source DB:  PubMed          Journal:  Phytother Res        ISSN： 0951-418X            Impact factor:   5.878


  5 in total

Review 1.  Ayurvedic treatments for diabetes mellitus.

Authors:  Kalpana Sridharan; Roshni Mohan; Sridharan Ramaratnam; Deepak Panneerselvam
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Pharmacognosy of Enicostemma littorale: a review.

Authors:  Rajamani Saranya; Thirunavukkarasu Thirumalai; Munisami Hemalatha; Ranganathan Balaji; Ernest David
Journal:  Asian Pac J Trop Biomed       Date:  2013-01

3.  Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus.

Authors:  Altaf Khan; Aziz Unnisa; Mo Sohel; Mohan Date; Nayan Panpaliya; Shweta G Saboo; Falak Siddiqui; Sharuk Khan
Journal:  In Silico Pharmacol       Date:  2021-12-02

4.  Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats.

Authors:  Hitesh Vaidya; Mandapati Rajani; Vasudevan Sudarsanam; Harish Padh; Ramesh Goyal
Journal:  J Nat Med       Date:  2009-07-25       Impact factor: 2.343

5.  A Small Molecule Swertisin from Enicostemma littorale Differentiates NIH3T3 Cells into Islet-Like Clusters and Restores Normoglycemia upon Transplantation in Diabetic Balb/c Mice.

Authors:  Nidheesh Dadheech; Sanket Soni; Abhay Srivastava; Sucheta Dadheech; Shivika Gupta; Renjitha Gopurappilly; Ramesh R Bhonde; Sarita Gupta
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.